Fundz

Bio Intelli Sense reported raising $58.1 Million in an initial SEC Form D filing, from an offering of $58.4 Million

PRIVATEDec 19, 2025$58.1M of $58.4M raised

Amount Raised

$58.1 Million

$58.1 Million sold, per SEC Form D (first sale Dec 4, 2025)

Round Type

Venture

GoldenHealthcareHealth Care

Investors

Royal PhilipsPendrell CorporationChicago Pacific FoundersChimera

Quick answer

BioIntelliSense raised $58.1 Million in a funding round, dated December 4, 2025. Investors: Royal Philips, Pendrell Corporation, Chicago Pacific Founders and Chimera. BioIntelliSense is based in Golden, Colorado, United States.

How much did BioIntelliSense raise?
BioIntelliSense raised $58.1 Million in a funding round on December 4, 2025.
Who invested in BioIntelliSense?
Royal Philips, Pendrell Corporation, Chicago Pacific Founders and Chimera are named as investors in this round.
What does BioIntelliSense do?
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).
Where is BioIntelliSense based and how big is it?
BioIntelliSense is based in Golden, Colorado, United States. Fundz records about 102 employees.
Who are the decision-makers at BioIntelliSense?
Fundz holds 2 contacts at BioIntelliSense, including the Vice President Sales - Oasis Virtual Care. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as BioIntelliSense that raised within 45 days of this round, from Fundz verified event records.

  • Novabay raised $134M on January 16, 2026.
  • Os Therapies raised $3.5M on January 14, 2026.
  • Tessera Defense & Homeland Security Inc. raised $3.3M on January 13, 2026.
  • Route 92 Medical raised $50M on January 13, 2026.
  • Kinaset Therapeutics raised $103M (Series B) on January 10, 2026.
  • Parabilis Medicines raised $305M (Series F) on January 8, 2026.

Who to call at BioIntelliSense, and when

A new round usually means BioIntelliSense is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioIntelliSense raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioIntelliSense, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioIntelliSense. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioIntelliSense

Location

17301 W. COLFAX AVENUE

Golden, Colorado, United States

About

BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical-grade remote care from in-hospital to home.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioIntelliSense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsKevin W., Vice President Sales - Oasis Virtual Ca…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BioIntelliSense's next move

See what Strategic adds

BioIntelliSense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.